Acarix AB (publ) (ACIXF)
OTCMKTS · Delayed Price · Currency is USD
0.0330
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Acarix AB Market Cap
Acarix AB has a market cap or net worth of $42.49 million as of February 12, 2026. Its market cap has increased by 82.36% in one year.
Market Cap
42.49M
Enterprise Value
39.76M
Revenue
734.28K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since December 19, 2016, Acarix AB's market cap has increased from 40.15M to 42.49M, an increase of 5.84%. That is a compound annual growth rate of 0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 43.02M | 18.94% |
| Dec 30, 2025 | 36.17M | 49.64% |
| Dec 30, 2024 | 24.17M | 74.25% |
| Dec 29, 2023 | 13.87M | 101.38% |
| Dec 30, 2022 | 6.89M | -71.64% |
| Dec 30, 2021 | 24.29M | 19.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tian'an Technology Group | 182.07M |
| Zomedica | 127.39M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.00M |
| Guided Therapeutics | 33.69M |
| Vivos | 33.66M |
| PetVivo Holdings | 27.73M |